Scarce Resources for Nuclear Detonation: Project Overview and Challenges

Determining how to help the medical community differentiate between efficacy of an intervention (best possible outcome) under normal circumstances and the effectiveness of an intervention (ability to complete the intervention) in the setting of critically scarce resources Conveying the importance of fairness and that “the greatest good for the greatest number of people” includes using some of the resources that could be used for lifesaving care to provide palliation/comfort for those who are in the expectant or delayed categories For society in general: Because of unprecedented resource scarcity, there is the need to change priorities from sickest first to those with serious but more effectively managed injury, and that crisis standards will be needed in the setting of severe shortages. [...]10 manuscripts were written to address the central topics. CAPT Judith Bader, MD, Radiation Oncologist, Senior Medical Advisor, NCI/NIH; Sylvia Brugge, Project Coordinator, DHHS; Brooke Buddemeier, CHP, Lawrence Livermore National Laboratory; Stephen V. Cantrill, MD, Principal Investigator Associate Director, Emergency Medical Services, BNICE Training Center, Department of Emergency Medicine, Denver Health Medical Center; Jamie Caro, MD, Senior Vice President, Health Economics, United BioSource Corporation; Rocco Casagrande, PhD, Managing Director, Gryphon Scientific; Nelson J. Chao, MD, Director, Duke University Bone Marrow and Stem Cell Transplant Program; C. Norman Coleman, MD, Associate Director, Radiation Research Program, Division of Cancer Treatment and Diagnosis, NCI/NIH; Susan Coller-Monarez, PhD, Program Analyst/Project Officer, OPEO; Evan DeRenzo, PhD, Senior Clinical Bioethicist, Center for Ethics, Washington Hospital Center; Daniel Dodgen, PhD, Director, Office for At Risk Individuals, Behavioral Health, and Human Services Coordination, ASPR/DHHS; Richard Hatchett, MD, Associate Director, Radiation Countermeasures Research and Emergency Preparedness, NIAID/DAIT; COL Pat Lillis-Hearn, MD, Director, Armed Forces Radiobiology Research Institute Uniformed Services University; John L. Hick, MD, Medical Director, Hennepin County Medical Center, Department of Emergency Medicine, University of Minnesota; Mary Beth Hill-Harmon, MSPH, Project Officer/Program Analyst, Modeling, BARDA/ASPR/DHHS; Jerry Holmberg, PhD, Senior Advisor for Blood Policy, DHHS, Executive Secretary, Advisory Committee on Blood Safety and Availability; Jimmie Jacobs, PhD, Senior Analyst, SAIC